Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (466)	10/20/2001 10:55:04 PM
From: tuck	Read Replies (1) of 1005

Drug Discovery & Development with an informative article on nanoliter pipetting. Mentions BLUE HP holdings CALP and VGNX, as well as potential BLUE HP candidate and CALP competitor ACLA. And some others lesser known and private or foreign. For example, an interesting comment by the Tecan guy about current systems aspirating more sample than they dispense. Will link this to the Trickle thread. dddmag.com VGNX with BDAL and Hamilton. Good products from good companies; worth spending some VGNX cash if well used. When will these desperate sellers run out of shares? Sheesh. Didn't somebody tell 'em mutual funds saw recent inflows? Must be VC. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next